Role of acute kidney injury biomarkers to guide renal replacement therapy initiation, what we learn from EARLY-RRT trial and FST trial?

Documenti analoghi

• Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial)
  di: Lumlertgul, Nuttha, et al.
  Pubblicazione: (2018)
• SEA-MAKE score as a tool for predicting major adverse kidney events in critically ill patients with acute kidney injury: results from the SEA-AKI study
  di: Sukmark, Theerapon, et al.
  Pubblicazione: (2020)
• 071 ANGIOPOIETIN-2 AS A BIOMARKER FOR PREDICTION OF MORTALITY AND RENAL RECOVERY IN PATIENTS REQUIRING RENAL REPLACEMENT THERAPY
  di: Nuttha Lumlertgul, et al.
  Pubblicazione: (2017-08-01)
• The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
  di: Srisawat, Nattachai, et al.
  Pubblicazione: (2018)
• Development and validation of point‐of‐care testing of albuminuria for early screening of chronic kidney disease
  di: Vutthikraivit, Nuntanuj, et al.
  Pubblicazione: (2021)